MedTrace Logo

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

NCT00418119 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2007-01-04

No results posted yet for this study

Summary

Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Conditions

Interventions

DRUG

erythropoietin

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Tuvia Ben Gal, MD · Cardiology Department Rabin medical Center

  • Ofer Shpilberg, Prof. · Hematology Department Rabin Medical Center

  • Daniel Murninkas, MD · Cardiology Department Rabin Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2008-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00418119 on ClinicalTrials.gov